摘要
目的探讨国产氯吡格雷与进口氯吡格雷治疗急性冠状动脉(冠脉)综合征(ACS)的成本效果。方法 100例急性冠脉综合征患者,随机分为观察组和对照组,每组50例。观察组给予国产氯吡格雷治疗,对照组给予进口氯吡格雷治疗。分析两组成本效果。结果观察组总有效率和对照组比较,差异无统计学意义(P>0.05)。观察组的成本为695.2元;对照组的成本为1480.0元。观察组成本效果为739.6;对照组成本效果为1541.7;观察组的成本效果低于对照组。结论国产氯吡格雷治疗急性冠脉综合征疗效显著,治疗成本低,值得借鉴。
Objective To investigate the cost effectiveness of indigenous clopidogrel and imported clopidogrel in the treatment of acute coronary syndrome （ACS）. Methods A total of 100 patients with acute coronary syndrome were randomly divided into observation group and control group, and each group contained 50 cases. The observation group was given indigenous clopidogrel for treatment, and the control group receivedimported elopidogrel. The cost effectiveness of the two groups was analyzed. Results Comparison between the total effective rates of the observation group and the control group showed there was no statistically significant difference （P〉0.05）. The observation group had the cost as 695.2 yuan, and that of the control group was 1480.0 yuan. The cost effectiveness was 739.6 in the observation group, and it was 1541.7 in the control group. The observation group had lower cost effectiveness than the control group. Conclusion Implement of indigenous clopidogrel in the treatment of acute coronary syndrome provides precise effect with low cost, and this method is worthy of reference.
出处
《中国现代药物应用》
2015年第9期31-33,共3页
Chinese Journal of Modern Drug Application
